Gregg says he had no history of liver problems and was in good health prior to using Ketek. "He survived 13 months in Iraq... to come home for this," says Sherry Gregg, his wife.

More disturbing is what some believe may be an FDA cover up of indications that the drug posed serious dangers to some.

Although it was created to fight respiratory infections and sinusitus, it may pose very serious health threats such as liver toxicity and in some cases, death resulting from liver failure. If you or a loved one has experienced a serious adverse reaction or illness while using Ketek and would like a free consultation with our firm, please contact us using the form at the right.

"The way the FDA under this nominee has handled the investigation of Ketek shows the agency would like to keep its business secret. It doesn't want these issues made public or subjected to the scrutiny."

Doug Greene, a doctor working for Sanofi-Aventis, the drug's manufacturer, insists the drug is safe enough for use, despite it's being on Public Citizen Health Watch's "Do Not Use" list since the summer of 2004. Ketek, which is also known as telithromycin, had $200 Million in sales in 2005.

acute exacerbation of chronic bronchitis; acute bacterial sinusitis; and community acquired pneumonia of mild to moderate severity, including pneumonia caused by resistant strep infections.

Since its 2004 FDA approval, Ketek has been linked to liver injury and failure in some cases, including four deaths and one liver transplant reported among Ketek users. Ketek's maker, Sanofi Aventis, plans to revise the drug's label to address these risks and concerns.